France 2030 : Lovaltech and Aptar Pharma, Laureates of France 2030

26 September 2023

More information on our Linkedin

Press release: ANSM authorization for the MUCOBOOST First in human, phase I & II clinical trial
14 March 2025
Press release: closing of Lovaltech seed financing round
24 April 2024
France 2030 : Lovaltech and Aptar Pharma, Laureates of France 2030
26 September 2023

This website use coockies and give you the control on what you want to activate. Accept all Personnalise